The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Open accessAbstract
Sepsis and septic shock are among the leading causes of death in intensive care units worldwide. Numerous studies on their pathophysiology have revealed an imbalance in the inflammatory network leading to tissue damage, organ failure, and ultimately, death. Cytokines are important pleiotropic regulators of the immune response, which have a crucial role in the complex pathophysiology underlying sepsis. They have both pro- and anti-inflammatory functions and are capable of coordinating effective defense mechanisms against invading pathogens. On the other hand, cytokines may dysregulate the immune response and promote tissue-damaging inflammation. In this review, we address the current knowledge of the actions of pro- and anti-inflammatory cytokines in sepsis pathophysiology as well as how these cytokines and other important immunomodulating agents may be therapeutically targeted to improve the clinical outcome of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Preliminary report: effects of interleukin-1 on platelet counts
Tewari, A., Starnes, H. F., & Buhles, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)92206-w · Cited by 159
RetractedBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762 · cited 1×
“In vitro, IL-10 suppresses the production of proinflammatory mediators, such as TNF-α, IL-1, IL-6, IFN-γ, and GM-CSF, in immune cells [85, 86].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100 · cited 1×
“IL-6 is a 21 kDa glycoprotein produced by a wide variety of cells, especially macrophages, dendritic cells, lymphocytes, endothelial cells, fibroblasts, and smooth muscle cells in response to stimulation with LPS, IL-1, and TNF-α [53–56].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778 · cited 1×
“Both are powerful proinflammatory cytokines that have been implicated in a large number of infectious and noninfectious inflammatory diseases, the latter including atherosclerosis [35], rheumatoid arthritis [36], osteoarthritis [105], and Alzheimer’s disease [38].”
BackgroundThe immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 1×
“A key function of IL-6 is the induction of fever [50] and the mediation of the acute phase response [51, 59], a systemic reaction to an inflammatory stimulus that is characterized by fever, leukocytosis, and the release of hepatic acute phase proteins such as C-reactive protein, complement components, fibrinogen, and…”
BackgroundOpal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Self-citationDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
Self-citationMIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,149
Self-citationThe Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
Steensberg, A., Fischer, C. P., Keller, C., Møller, K., & Pedersen, B. K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2003 · Cited by 1,135
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,102
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
The interactions between inflammation and coagulation
Esmon, C. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05753.x · Cited by 1,003
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 999
Self-citationSeder, R. A., Paul, W. E., Davis, M. M., & Fazekas de St Groth, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1091 · Cited by 997
Calandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1895 · Cited by 985
Self-citationLevi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 853
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
Taylor, F. B., Chang, A., Esmon, C. T., D'Angelo, A., Vigano-D'Angelo, S., & Blick, K. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112902 · Cited by 821
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Apoptosis and caspases regulate death and inflammation in sepsis
Hotchkiss, R. S., & Nicholson, D. W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1943 · Cited by 795
Interleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1205 · Cited by 792
Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J. P., & Cavaillon, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115493 · Cited by 754
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 751
Response of Serum Interleukin-6 in Patients Undergoing Elective Surgery of Varying Severity
Cruickshank, A. M., Fraser, W. D., Burns, H. J. G., Van Damme, J., & Shenkin, A. (1990) · Clinical Science · doi:10.1042/cs0790161 · Cited by 745
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin
Wheelock, E. F. (1965) · Science · doi:10.1126/science.149.3681.310 · Cited by 725
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Self-citationEsmon, C. T. (2003) · Chest · doi:10.1378/chest.124.3_suppl.26s · Cited by 719
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.020 · Cited by 677
Self-citationActivation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
van der Poll, T., Büller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Fong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. C., Allison, A. C., & Lowry, S. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1627 · Cited by 641
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Inflammation, endothelium, and coagulation in sepsis
Schouten, M., Wiersinga, W. J., Levi, M., & van der Poll, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607373 · Cited by 629
Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., & Bucala, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 622
Self-citationThe interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress
O'Neill, L. A. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00701.x · Cited by 616
MIF regulates innate immune responses through modulation of Toll-like receptor 4
Roger, T., David, J., Glauser, M. P., & Calandra, T. (2001) · Nature · doi:10.1038/414920a · Cited by 584
Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C., Wong, G. H., Chen, E. Y., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2830 · Cited by 567
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis
Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., & David, J. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.341 · Cited by 551
Calandra, T., Baumgartner, J.-D., Grau, G. E., Wu, M.-M., Lambert, P.-H., Schellekens, J., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 547
Cytokine appearance in human endotoxemia and primate bacteremia.
HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532
Regulation of interferon-γ production by IL-12 and IL-18
Okamura, H., Kashiwamura, S.-I., Tsutsui, H., Yoshimoto, T., & Nakanishi, K. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80163-5 · Cited by 523
Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
Dinarello, C. A. (1997) · Chest · doi:10.1378/chest.112.6_supplement.321s · Cited by 508
Cohen, J., & Carlet, J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00002 · Cited by 501
Host Innate Immune Receptors and Beyond: Making Sense of Microbial Infections
Ishii, K. J., Koyama, S., Nakagawa, A., Coban, C., & Akira, S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.003 · Cited by 499
Sepsis and cytokines: current status
Blackwell, T. S., & Christman, J. W. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/77.1.110 · Cited by 459
Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C., & Volk, H. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1887 · Cited by 445
The ‘cytokine profile’: a code for sepsis
Ulloa, L., & Tracey, K. J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.007 · Cited by 440
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
Dinarello, C. A. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006129 · Cited by 435
Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., & Young, L. H. (2008) · Nature · doi:10.1038/nature06504 · Cited by 429 · cited 1×
“Recently, MIF was established as an important mediator of LPS-induced myocardial dysfunction [173, 174].”
BackgroundSelf-citationFISHER, C. J., OPAL, S. M., DHAINAUT, J.-F., STEPHENS, S., ZIMMERMAN, J. L., NIGHTINGALE, P., HARRIS, S. J., SCHEIN, R. M. H., PANACEK, E. A., VINCENT, J.-L., et al. (1993) · Critical Care Medicine · doi:10.1097/00003246-199303000-00006 · Cited by 427
Wang, Z. E., Reiner, S. L., Zheng, S., Dalton, D. K., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1367 · Cited by 392
BOGDAN, C., & NATHAN, C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35934.x · Cited by 384
van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J., Eerenberg, A. J., de Groot, E. R., Jansen, J., Gallati, H., & Büller, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1253 · Cited by 383
Immunotherapy for Sepsis — A New Approach against an Ancient Foe
Hotchkiss, R. S., & Opal, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1004371 · Cited by 367
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A., O'Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 362
Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., Goldbach-Mansky, R., Pizarro, T., Hoffman, H., Bufler, P., et al. (2010) · Nature Immunology · doi:10.1038/ni1110-973 · Cited by 351
Borrelli, E., Roux-Lombard, P., Grau, G. E., Girardin, E., Ricou, B., Dayer, J.-M., & Suter, P. M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00006 · Cited by 349
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Chai, Z., Gatti, S., Toniatti, C., Poli, V, & Bartfai, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.311 · Cited by 343
Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., & Bloedow, D. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115748 · Cited by 333
Pittet, D., Rangel-Frausto, S., Li, N., Tarara, D., Costigan, M., Rempe, L., Jebson, P., & Wenzel, R. P. (1995) · Intensive Care Medicine · doi:10.1007/bf01705408 · Cited by 329
Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
Rincon, M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.003 · Cited by 328
CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS
van der Poll, T., & van Deventer, S. J. H. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70083-0 · Cited by 323
Al-Abed, Y., Dabideen, D., Aljabari, B., Valster, A., Messmer, D., Ochani, M., Tanovic, M., Ochani, K., Bacher, M., Nicoletti, F., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500243200 · Cited by 307
Development of chronic colitis is dependent on the cytokine MIF
de Jong, Y. P., Abadia-Molina, A. C., Satoskar, A. R., Clarke, K., Rietdijk, S. T., Faubion, W. A., Mizoguchi, E., Metz, C. N., Sahli, M. A., ten Hove, T., et al. (2001) · Nature Immunology · doi:10.1038/ni720 · Cited by 305
Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B., Mitchell, R., Lolis, E., & Al-Abed, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203220200 · Cited by 304
Interleukin-6 and its receptor: from bench to bedside
Scheller, J., & Rose-John, S. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0019-9 · Cited by 292
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., & Ryffel, B. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1437 · Cited by 290
Goldie, A. S. (1995) · JAMA · doi:10.1001/jama.274.2.172 · Cited by 289
Endogenous IL-10 protects mice from death during septic peritonitis
van der Poll, T., Marchant, A., Buurman, W. A., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5397 · Cited by 285
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Estaquier, J., Idziorek, T., Zou, W., Emilie, D., Farber, C. M., Bourez, J. M., & Ameisen, J. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1759 · Cited by 273
Bernard, G. R., Ely, E. W., Wright, T. J., Fraiz, J., Stasek, J. E., Russell, J. A., Mayers, I., Rosenfeld, B. A., Morris, P. E., Yan, S. B., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200111000-00003 · Cited by 271
Alberti, C., Brun-Buisson, C., Goodman, S. V., Guidici, D., Granton, J., Moreno, R., Smithies, M., Thomas, O., Artigas, A., & Le Gall, J. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-785oc · Cited by 262
Effects of accidental trauma on cytokine and endotoxin production
HOCH, R. C., RODRIGUEZ, R., MANNING, T., BISHOP, M., MEAD, P., SHOEMAKER, W. C., & ABRAHAM, E. (1993) · Critical Care Medicine · doi:10.1097/00003246-199306000-00010 · Cited by 262
Mikulowska, A., Metz, C. N., Bucala, R., & Holmdahl, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5514 · Cited by 258
Self-citationThe role of IFN-gamma in the pathology of experimental endotoxemia.
Heinzel, F. P. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2920 · Cited by 255
Sporn, M. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070086036 · Cited by 246
Leentjens, J., Kox, M., Koch, R. M., Preijers, F., Joosten, L. A. B., van der Hoeven, J. G., Netea, M. G., & Pickkers, P. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0645oc · Cited by 244
Merk, M., Zierow, S., Leng, L., Das, R., Du, X., Schulte, W., Fan, J., Lue, H., Chen, Y., Xiong, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102941108 · Cited by 241
Self-citationCalandra, T., Spiegel, L. A., Metz, C. N., & Bucala, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11383 · Cited by 235
Self-citationClinical Aspects: From Systemic Inflammation to 'Immunoparalysis�
Volk, H.-D., Reinke, P., & D�cke, W.-D. (1999) · Chemical Immunology and Allergy · doi:10.1159/000058753 · Cited by 233
Role of Interleukin-6 in Mortality from and Physiologic Response to Sepsis
Remick, D. G., Bolgos, G., Copeland, S., & Siddiqui, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2751-2757.2005 · Cited by 230
Spinas, G. A., Keller, U., & Brockhaus, M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115891 · Cited by 227
Zhang, X. L., Topley, N., Ito, T., & Phillips, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413284200 · Cited by 219
Rossi, A. G., Haslett, C., Hirani, N., Greening, A. P., Rahman, I., Metz, C. N., Bucala, R., & Donnelly, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1524 · Cited by 218
Self-citationSherman, M. L., Spriggs, D. R., Arthur, K. A., Imamura, K., Frei, E., & Kufe, D. W. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.344 · Cited by 215
Sensing disease and danger: A survey of vertebrate PRRs and their origins
Hansen, J. D., Vojtech, L. N., & Laing, K. J. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.01.008 · Cited by 214
Macrophage Migration Inhibitory Factor: A Probable Link between Inflammation and Cancer
Bucala, R., & Donnelly, S. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.005 · Cited by 210
Self-citationPresneill, J. J., Harris, T., Stewart, A. G., Cade, J. F., & Wilson, J. W. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009005 · Cited by 208
Tumour necrosis factor in man: Clinical and biological observations
Selby, P., Hobbs, S., Viner, C., Jackson, E., Jones, A., Newell, D., Calvert, A., McElwain, T., Fearon, K., & Humphreys, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.294 · Cited by 204
Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
Alberti, C., Brun-Buisson, C., Chevret, S., Antonelli, M., Goodman, S. V., Martin, C., Moreno, R., Ochagavia, A. R., Palazzo, M., Werdan, K., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-324oc · Cited by 194
Interleukin-10 Controls the Onset of Irreversible Septic Shock
Latifi, S. Q., O'Riordan, M. A., & Levine, A. D. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4441-4446.2002 · Cited by 194
Inhibitor of Apoptosis Protein cIAP2 Is Essential for Lipopolysaccharide-Induced Macrophage Survival
Conte, D., Holcik, M., Lefebvre, C. A., LaCasse, E., Picketts, D. J., Wright, K. E., & Korneluk, R. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.699-708.2006 · Cited by 191
TGF-β and Regulatory T Cell in Immunity and Autoimmunity
Wan, Y. Y., & Flavell, R. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9251-y · Cited by 186
Roger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184 · cited 1×
“MIF’s critical role within the immune system is further underscored by the finding that MIF is induced by low concentrations of glucocorticoids and has the unique ability to override the anti-inflammatory and immunosuppressive effects of glucocorticoids [77, 81, 84].”
BackgroundPolk, H. C., Cheadle, W. G., Livingston, D. H., Rodriguez, J. L., Starko, K. M., Izu, A. E., Jaffe, H. S., & Sonnenfeld, G. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90099-d · Cited by 178
Yanagida, M., Fukamachi, H., Ohgami, K., Kuwaki, T., Ishii, H., Uzumaki, H., Amano, K., Tokiwa, T., Mitsui, H., & Saito, H. (1995) · Blood · doi:10.1182/blood.v86.10.3705.bloodjournal86103705 · Cited by 177
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Merk, M., Mitchell, R. A., Endres, S., & Bucala, R. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.014 · Cited by 176
Self-citationGenome-wide transcription profiling of human sepsis: a systematic review
Tang, B. M., Huang, S. J., & McLean, A. S. (2010) · Critical Care · doi:10.1186/cc9392 · Cited by 169
Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β
Turner, M., Chantry, D., Katsikis, P., Berge, A., Brennan, F. M., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210708 · Cited by 163
Beishuizen, A., THIJS, L. G., Haanen, C., & Vermes, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7570 · Cited by 162
Arjona, A., Foellmer, H. G., Town, T., Leng, L., McDonald, C., Wang, T., Wong, S. J., Montgomery, R. R., Fikrig, E., & Bucala, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32218 · Cited by 158
Self-citationThe acute phase response: General aspects
Kushner, I., & Rzewnicki, D. (1994) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80113-x · Cited by 155
Circulating cytokines: the tip of the iceberg?
Cavaillon, J., Muñoz, C. A. O., Fitting, C., Misset, B., & Carlet, J. M. (1992) · PubMed · Cited by 155
Kuhns, D. B., Alvord, W. G., & Gallin, J. I. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.145 · Cited by 152
Economic Aspects of Severe Sepsis
Burchardi, H., & Schneider, H. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422120-00003 · Cited by 144
Zamorano, J., Wang, H. Y., Wang, L. M., Pierce, J. H., & Keegan, A. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4926 · Cited by 143
Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park, J. Y., & Pillinger, M. H. (2007) · PubMed · Cited by 143
Leng, L., Chen, L., Fan, J., Greven, D., Arjona, A., Du, X., Austin, D., Kashgarian, M. J., Yin, Z., Huang, X. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001767 · Cited by 142
Self-citationRegulation of inflammatory responses by natural anticoagulants
Okajima, K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1840123.x · Cited by 141
Song, G. Y., Chung, C., Chaudry, I. H., & Ayala, A. (1999) · Surgery · doi:10.1016/s0039-6060(99)70180-7 · Cited by 137
Lutz, M. B., Schnare, M., Menges, M., Rößner, S., Röllinghoff, M., Schuler, G., & Gessner, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3574 · Cited by 134
Role of IL-6 in the Pleurisy and Lung Injury Caused by Carrageenan
Cuzzocrea, S., Sautebin, L., Sarro, G. D., Costantino, G., Rombolà, L., Mazzon, E., Ialenti, A., Sarro, A. D., Ciliberto, G., Rosa, M. D., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5094 · Cited by 134
De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in Rabbits
Shu-guang, L., Yu, X., Chen, Y., Huang, X. R., Metz, C. N., Bucala, R., Lau, C., & Lan, H. Y. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1202 · Cited by 129
Self-citationThe Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor
Merk, M., Baugh, J. A., Zierow, S., Leng, L., Pal, U., Lee, S. J., Ebert, A., Mizue, Y., Trent, J. O., Mitchell, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803710 · Cited by 127
Self-citationNijsten, M. W., Hack, C. E., Helle, M., et al. (1991) · PubMed · Cited by 125
Historical perspective of the word “sepsis”
Geroulanos, S., & Douka, E. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0392-2 · Cited by 121
Atsumi, T., Cho, Y.-R., Leng, L., McDonald, C., Yu, T. Y., Danton, C., Hong, E., Mitchell, R. A., Metz, C. N., Niwa, H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5399 · Cited by 119
Self-citationCytokine modulation in sepsis and septic shock
Zanotti, S. L., Kumar, A., & Kumar, A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.8.1061 · Cited by 117
Seitz, M., Loetscher, P., Dewald, B., Towbin, H., Gallati, H., & Baggiolini, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250443 · Cited by 116
Creasey, A. A., Stevens, P., Kenney, J., ALLISON, A. C., Warren, K., Catlett, R., Hinshaw, L. B., & Taylor, F. B. (1991) · PubMed · Cited by 115
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily
Jones, L. L., & Vignali, D. A. A. (2011) · Immunologic Research · doi:10.1007/s12026-011-8209-y · Cited by 114
A critical role for citrate metabolism in LPS signalling
O'Neill, L. A. J. (2011) · Biochemical Journal · doi:10.1042/bj20111386 · Cited by 111
T helper cell subset ratios in patients with severe sepsis
Ferguson, N. R., Galley, H. F., & Webster, N. R. (1999) · Intensive Care Medicine · doi:10.1007/s001340050795 · Cited by 109
Emonts, M., Sweep, F. C. G. J., Grebenchtchikov, N. I., Geurts-Moespot, A. J., Knaup, M., Chanson, A.-L., Erard, V., Renner, P., Hermans, P. W. M., Hazelzet, J. A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514344 · Cited by 109
Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog
Preiser, J., Schmartz, D., der Linden, P. V., Content, J., Bussche, P. V., Buurman, W. A., Sebald, W., Dupont, É., Pinsky, M. R., & Vincent, J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90002-u · Cited by 104
da Silva, F. P., & Nizet, V. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0320-3 · Cited by 102
Multiple Roles for IL-12 in a Model of Acute Septic Peritonitis
Steinhauser, M. L., Hogaboam, C. M., Lukacs, N. W., Strieter, R. M., & Kunkel, S. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5437 · Cited by 100
Maintaining system homeostasis: the third law of Newtonian immunology
Germain, R. N. (2012) · Nature Immunology · doi:10.1038/ni.2404 · Cited by 99
New insights into adipose tissue dysfunction in insulin resistance
Mlinar, B., & Marc, J. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.697 · Cited by 99
Moreno, S. E., Alves-Filho, J. C., Alfaya, T. M., Silva, J. S., Ferreira, S. H., & Liew, F. Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3218 · Cited by 97
Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation.
Witsell, A. L., & Schook, L. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4763-b · Cited by 94
Advances in understanding sepsis
Shimaoka, M., & Park, E. J. (2008) · European Journal of Anaesthesiology · doi:10.1017/s0265021507003389 · Cited by 93
Chalupka, A. N., & Talmor, D. S. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.09.003 · Cited by 91
Rosenbloom, A. J., Linden, P. K., Dorrance, A. M., Penkosky, N., Cohen-Melamed, M. H., & Pinsky, M. R. (2005) · CHEST Journal · doi:10.1378/chest.127.6.2139 · Cited by 91
Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor
Garner, L. B., Willis, M. S., Carlson, D., DiMaio, J. M., White, M., White, D. J., Adams, G. A., Horton, J. W., & Giroir, B. P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00432.2003 · Cited by 90
Arrest of endotoxin-induced hypotension by transforming growth factor beta1.
Perrella, M. A., Hsieh, C.-M., Lee, W. S., Shieh, S., Tsai, J. C.-S., Patterson, C., Lowenstein, C. J., Long, N. C., Haber, E., Shore, S. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2054 · Cited by 90
Yende, S. P., Angus, D. C., Kong, L., Kellum, J. A., Weissfeld, L. A., Ferrell, R. E., Finegold, D. N., Carter, M., Leng, L., Peng, Z., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-129445 · Cited by 88
Self-citationFong, P., Argent, B. E., Guggino, W. B., & Gray, M. A. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00509.2002 · Cited by 87
Jansen, P. M., Kraan, T. C. T. M. V. D. P., de Jong, I., van Mierlo, G. J., Wijdenes, J., Chang, A., Aarden, L. A., Taylor, F. B., & Hack, C. E. (1996) · Blood · doi:10.1182/blood.v87.12.5144.bloodjournal87125144 · Cited by 82
Zisman, D. A., Kunkel, S. L., Strieter, R. M., Gauldie, J., Tsai, W. C., Bramson, J. L., Wilkowski, J. M., Bucknell, K. A., & Standiford, T. J. (1997) · Shock · doi:10.1097/00024382-199711000-00006 · Cited by 77
Interleukin-6: a cytokine with potential diagnostic and therapeutic roles.
Ec, B., & Chin, P. (1994) · PubMed · Cited by 75
Baumhofer, J. M., Beinhauer, B. G., Wang, J. E., Brandmeier, H., Geissler, K. H., Losert, U. M., Philip, R., Aversa, G., & Rogy, M. A. (1998) · European Journal of Immunology · Cited by 74
Experimental Therapeutic Strategies for Severe Sepsis: Mediators and Mechanisms
Parrish, W. R., Gallowitsch‐Puerta, M., Czura, C. J., & Tracey, K. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.011 · Cited by 74
Awandare, G. A., Martinson, J. J., Were, T., Ouma, C., Davenport, G. C., Ong’echa, J. M., Wang, W., Leng, L., Ferrell, R. E., Bucala, R., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600894 · Cited by 74
Self-citationDamage- and Pathogen-Associated Molecular Patterns and Alarmins: Keys to Sepsis?
Denk, S., Perl, M., & Huber-Lang, M. S. (2012) · European Surgical Research · doi:10.1159/000338194 · Cited by 71
Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation.
Witsell, A. L., & Schook, L. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4754 · Cited by 67
Elevated Levels of Circulating Transforming Growth Factor-β 1 in Patients with the Sepsis Syndrome
Marie, C., Cavaillon, J., & Losser, M.-R. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-6-199609150-00034 · Cited by 66
Kobayashi, S., Nishihira, J., Watanabe, S., & Todo, S. (1999) · Hepatology · doi:10.1002/hep.510290610 · Cited by 65
Weighardt, H., Heidecke, C.-D., Westerholt, A., Emmanuilidis, K., Maier, S., Veit, M., Gerauer, K. E., Matevossian, E., Ulm, K., Siewert, J., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00015 · Cited by 65
New insights into immunological aspects of atherosclerosis
Jawień, J. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.332 · Cited by 63
Hare, A. A., Leng, L., Gandavadi, S., Du, X., Cournia, Z., Bucala, R., & Jorgensen, W. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.129 · Cited by 63
Self-citationProtective mechanisms of activated protein C in severe inflammatory disorders
Neyrinck, A., Liu, K. D., Howard, J. P., & Matthay, M. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00251.x · Cited by 57
Wu, H.-P., Shih, C.-C., Lin, C., Hua, C., & Chuang, D. (2011) · Critical Care · doi:10.1186/cc10464 · Cited by 55
Cited by
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
Kang, S., & Kishimoto, T. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00649-0 · Cited by 375
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 369
Metadata
- Authors
- Schulte, W., Bernhagen, J., & Bucala, R.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-16
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W1966778344
- Cited by
- 745
- References
- 220
- FWCI
- 22.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.